You are here

AMX0035

Amylyx completes subject enrollment in ALS therapy trial

Clinical Trials Arena

Fri, 02/3/23 - 10:33 am

clinical trials

Highlighted by Amylyx, the ALS Space is Gaining Momentum

BioSpace

Fri, 09/9/22 - 11:11 am

NeuroSense Therapeutics

BrainStorm Cell Therapeutics

FDA advisers back Amylyx ALS drug, reversing earlier position

BioPharma Dive

Thu, 09/8/22 - 12:00 am

Go or no go? Bristol’s Tyk2 test

EP Vantage

Wed, 08/31/22 - 10:15 am

Bristol Myers Squibb

deucravacitinib

Amylyx Pharmaceuticals

Ferring Pharmaceuticals

Revance Therapeutics

Spectrum Pharmaceuticals

FDA to reconvene experts' meeting for Amylyx ALS drug

Yahoo/Reuters

Tue, 07/5/22 - 10:48 am

Go or no go? The FDA’s Amylyx dilemma

EP Vantage

Tue, 05/31/22 - 10:29 am

Moderna Therapeutics

Amylyx Augments Case for ALS Drug Ahead of PDUFA Date

BioSpace

Thu, 05/5/22 - 11:30 pm

An FDA panel reviewing Amylyx's ALS drug was moved by patient testimony—but they voted it down anyway

Fierce Biotech

Thu, 03/31/22 - 10:48 am

Amylyx faces an uphill battle

EP Vantage

Wed, 03/30/22 - 10:42 am

Go or no go? Bristol’s Lag3 debut

EP Vantage

Fri, 02/25/22 - 10:21 am

Bristol Myers Squibb

Amylyx, faced with longer FDA path for promising ALS drug, gets major cash infusion

BioPharma Dive

Tue, 07/20/21 - 12:31 pm

Amylyx Pharmaceuticals

venture capital

FDA faces backlash after seeking more data on an experimental ALS therapy

BioPharma Dive

Wed, 04/14/21 - 09:53 pm

Amylyx Pharmaceuticals

Early signs of survival benefit raise optimism around a small biotech's ALS drug

BioPharma Dive

Sun, 10/18/20 - 12:03 am

Amylyx Pharmaceuticals

After a rare win, a biotech details long-awaited results for its ALS drug

BioPharma Dive

Wed, 09/2/20 - 07:54 pm